Latest News

Adenotonsillectomy Doesn't Better Cognitive Function in Kids Early adenotonsillectomy improved quality of life, symptoms, behavior, and blood pressure compared with watchful waiting.
Medscape Medical News, December 22, 2023
Paradoxical Eczema Risk Low With Biologic Psoriasis Tx Ali Al-Janabi, MA, and associates found that 273 (1%) of approximately 25,000 drug exposures in 13,699 biologic-treated patients with psoriasis were associated with paradoxical eczema.
MDedge News, December 22, 2023
FDA Denies Accelerated Approval for ALS Drug The FDA has rejected Clene Nanomedicine's application for accelerated approval for the experimental drug ALS drug, CNM-Au8, citing insufficient evidence.
Medscape Medical News, December 21, 2023
Flavored E-cigs Still Sold to Minors, Despite Law Online sales of flavored e-cigarettes to minors appeared to continue, despite a California law.
Medscape Medical News, December 21, 2023
Ukrainian Lawmakers Back Legalisation Of Medical Cannabis Ukrainian lawmakers voted to legalise the medical use of cannabis on Thursday after activists and supporters called for the step in order to treat millions of people...
Reuters Health Information, December 21, 2023
How an Obesity Drug Could Help Alcohol Use Disorder Promising preclinical and early clinical data suggest a role for GLP-1 receptor agonist therapy in treating alcohol use disorder.
Medscape Medical News, December 21, 2023
Docs Win $7 Million Settlement in Forced Retirement Case For 2 years, a San Diego–based medical group required physicians to quit at age 75.
Medscape Medical News, December 21, 2023
Many Patients With Type 2 Diabetes Stop Meds After a Year Often, patients with type 2 diabetes on second-line medication discontinue their therapy within a year, warn US researchers who highlight the need for new prescribing approaches.
Medscape Medical News, December 21, 2023
Evaluating Aesthetic Concerns Among Hispanic, Latinx Women To date, the aesthetic needs of Hispanic/Latinx patients, the second largest ethnic group in the United States, have been poorly understood.
MDedge News, December 21, 2023
New Research Aims to Unravel Both ME/CFS and Long COVID A 2-day research conference sponsored by the US National Institutes of Health highlighted research that points to mechanisms that suggest potentially "druggable" pathways.
Medscape Medical News, December 21, 2023
Low-Dose Naltrexone Researcher Disputes Study Negativity Neuroinflammation expert Jarred Younger, PhD, disputes commentary calling for clinicians to stop prescribing the off-label compounded medication to reduce pain in people with fibromyalgia.
Medscape Medical News, December 21, 2023
When's Best to Re-dose Rituximab After Vasculitis Remission? A single-center study found that using B-cell levels to determine when to infuse rituximab reduced relapses in patients antineutrophil cytoplasmic antibody vasculitis.
Medscape Medical News, December 21, 2023
A New Test Could Save Arthritis Patients Time, Money, Pain Stories of chronic pain, drug-hopping, and insurance meddling are all too common among patients with rheumatoid arthritis. Precision medicine offers new hope.
KFF Health News, December 21, 2023
The Latest Findings on Major Breast Cancer Trials Here's a roundup of the most recent data from five phase 3 trials presented at SABCS 2023.
Medscape Medical News, December 21, 2023
Serum Hormones May Predict AI Benefit for BC Prevention Measuring serum hormone concentrations in postmenopausal women at high risk for developing BC may help identify those most likely to benefit from preventive treatment with an aromatase inhibitor.
Medscape Medical News, December 21, 2023
COVID Strain JN.1 Is Now a 'Variant of Interest,' WHO Says JN.1 was previously grouped with its relative, BA.2.86, but has increased so much in the past 4 weeks that the WHO moved it to standalone status.
WebMD Health News, December 21, 2023
US FDA Declines to Approve Merck's Chronic Cough Drug The U.S. Food and Drug Administration (FDA) declined to approve Merck's drug for chronic cough, the company said on Wednesday, marking the second rejection in less than two...
Reuters Health Information, December 20, 2023
US FDA Approves Sweden-based Calliditas' Kidney Disease Drug The U.S. Food and Drug Administration (FDA) granted full approval to Swedish drugmaker Calliditas Therapeutics' drug to treat rare kidney disease IgA Nephropathy (IgAN), the...
Reuters Health Information, December 20, 2023
French Drugmaker Servier Ordered to Pay $471 Million for Mediator Scandal Drugmaker Servier must pay more than 430 million euros ($471 million) in connection with weight-loss pill Mediator, a French court ruled on Wednesday, saying the company was...
Reuters Health Information, December 20, 2023
Despite X-Waiver Elimination, Buprenorphine Rx Decline After the elimination of the mandatory training required to prescribe buprenorphine for opioid use disorder, prescriptions for the drug declined the next year, new research shows.
Medscape Medical News, December 20, 2023
Replimune Skin Cancer Therapy Fails Midstage Study Replimune Group said on Tuesday its experimental combination therapy to treat a common form of skin cancer failed to significantly remove or reduce cancerous lesions in a midstage study.
Reuters Health Information, December 05, 2023
Alcohol Taxes Aren't High Enough, Says World Health Organization WHO urged governments on Tuesday to increase taxes on alcoholic drinks and impose them on products that are currently exempt, such as wine in some European countries.
Reuters Health Information, December 05, 2023
CVS Plans to Simplify Drug Pricing Process CVS Health on Tuesday forecast 2024 revenue above market estimates and said it would simplify the structure through which its pharmacies get reimbursed for drugs.
Reuters Health Information, December 05, 2023
US Regulators Inspect Dr Reddy's, Other Indian Pharma Majors The US Food and Drug Administration is inspecting Dr Reddy's research and development centre in the southern Indian city of Hyderabad, the pharma company said on Tuesday.
Reuters Health Information, December 05, 2023
Eli Lilly Obesity Drug Now Available in US Pharmacies
Reuters Health Information, December 05, 2023
Roche Joins Race for Obesity Drugs With $2.7 Billion Carmot Deal Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk and Eli Lilly.
Reuters Health Information, December 04, 2023
MSWS 2023 What's New in Acne Treatment? Advances in acne care include the use of light-based devices.
Medscape Medical News, December 04, 2023
How the New Outbreak in China Is Hitting Clinics Elsewhere A rise in respiratory illnesses in China, clusters of pneumonia in children, and resistance to common antibiotics have specialists on alert looking for changes locally.
Medscape Medical News, December 04, 2023
'Hidden Hearing Loss' May Cause Tinnitus: Study Some people who have tinnitus are still able to perform well on standard hearing tests, according to researchers at the Massachusetts Eye and Ear Infirmary.
WebMD Health News, December 04, 2023
ASH 2023 ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.
MDedge News, December 04, 2023
Analysis Supports Link Between Psoriasis and OSA Several hypotheses may explain the connection, such as the presence of inflammatory mediators and nocturnal cytokine secretion, according to the authors.
Medscape Medical News, December 04, 2023
Reducing Albumin Improves Kidney and Heart Function The tablet drug finerenone significantly reduces kidney risk in people with type 2 diabetes and also protects heart health, researchers found.
Medscape Medical News, December 04, 2023
Statin Use Remains Low for At-Risk Patients Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease.
Medscape Medical News, December 04, 2023
No Benefit of Levothyroxine in Heart Donors New data challenge the common practice of levothyroxine administration in potential heart donors after brain death to preserve heart function and make more hearts available for transplantation.
Medscape Medical News, December 04, 2023
How the Microbiome Influences the Success of Cancer Therapy Microbial diversity affects whether a tumor grows, leads to inflammation, develops immune escape mechanisms, or develops therapeutic resistance, said an internal medicine specialist.
Medscape Medical News, December 04, 2023
An ED Nurse Crosses Busy Freeway to Save a Life When a huge cement truck slams into a freeway retaining wall, an ED nurse on her way home jumps in with no equipment to prevent a bleed-out.
Medscape Medical News, December 04, 2023
How Gender-Affirming Treatment Affects Erythrocytosis Gender-affirming hormone therapy has been associated with a risk for abnormal blood cell elevation, but a new study finds that it is a lower risk than was previously believed.
Medscape Medical News, December 04, 2023
AES 2023 Poverty Tied to Poor Cognition in Patients With Epilepsy Mounting research links poverty and other elements of neighborhood deprivation to worse cognition in people with epilepsy.
Medscape Medical News, December 04, 2023
Experimental Tx Restores Cognitive Function in Chronic TBI In a first-in-humans trial, deep brain stimulation restored executive function in five individuals with moderate to severe traumatic brain injury 3-18 years after injury.
Medscape Medical News, December 04, 2023
US Obesity Docs Expect Zepbound to Show Heart Benefit Some leading US obesity specialists say they expect Eli Lilly’s powerful weight-loss drug Zepbound will produce the same or similar heart benefits as Novo Nordisk’s popular Wegovy.
Reuters Health Information, December 01, 2023

No Results